14 Οκτ 2026
Adults with psoriasis can join HPOS, and eligible participants may also take part in the iPROLEPSIS IDBV Study
Psoriasis may be most visible on the skin, but its impact can go much further. Up to one in three people with psoriasis may develop psoriatic arthritis (PsA), an inflammatory disease affecting the joints and tendons. Yet it is still difficult to predict who will develop PsA – and who will not.
The HIPPOCRATES Prospective Observational Study (HPOS) is working to change that by following people with psoriasis over three years and looking for early signs linked to the development of PsA. Conducted entirely online, with no hospital visits required, the study enables people in participating countries across Europe to contribute their experiences from home.
This World Psoriasis Day focuses on young people living with psoriasis under the campaign slogan #LookBeyondMySkin. By investigating what happens before PsA develops, HPOS aims to improve our understanding of the disease and, ultimately, the outlook for future generations.
Join HPOS and help shape what comes next
HPOS is open to adults living in participating European countries who have psoriasis and have not been diagnosed with psoriatic arthritis. Taking part is flexible and designed to fit around participants’ everyday lives.
Find out if you are eligible and register: https://hpos.study/
Connecting HPOS with iPROLEPSIS
HPOS participants who meet the eligibility criteria may also be able to take part in the iPROLEPSIS Inflammation Digital Biomarkers Validation (IDBV) Study. The study is exploring whether information from a smartphone could help researchers detect early changes linked to psoriatic arthritis.
Participants who join the IDBV Study use the miPROLEPSIS Lite app on their smartphone for up to 12 months. Designed to fit into real life, the app collects most of the information needed for the study automatically, so there is very little for participants to do. Researchers want to understand whether changes in movement, activity and symptoms can be detected earlier using digital information collected through the study app.
Learn more about the iPROLEPSIS IDBV Study and miPROLEPSIS Lite:
